novo glp 1 drugs asks FDA to prevent compounders from making GLP-1 knockoffs FDA asks for removal of

Other research found a slightly higher rate of NAION in people using semaglutide, both for type 2 diabetes and weight loss

However, for those who choose medication-based treatment, its important to understand that these therapies are not short-term fixesthey typically require ongoing use to sustain results. Mir Ali, MD Although the results appear promising, the studies primarily evaluated people who had already responded well to treatment and tolerated the medications

If your state opts in, you could access GLP-1s for weight management at significantly lower cost

Better yet, ask for a cystatin C test instead of creatinine-based eGFR if you want an accurate picture of kidney function while supplementing with creatine

According to one observational study carried out in Japan, emotional eaters were less likely to see significant weight changes when using a GLP-1 drug treatment

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in women: diagnosis and treatment: number 11-2024